storage temp.
2-8°C
Quality Level
General description
TAP 技术是蛋白质纯化的最新进展。该技术将串联的亲和标签整合到感兴趣的基因中，从而可以通过两个连续的亲和纯化步骤分离出高纯度的融合蛋白。该技术特别适用于通过向已知的“诱饵”蛋白添加串联亲和标签来分离和鉴定蛋白质复合物，以减少与目标靶蛋白相互作用的内源蛋白质。
Application
FLAG ® HA串联亲和纯化试剂盒专门设计用于从复杂基质（如细胞裂解物和组织匀浆液）中分离高纯度FLAG-HA双标签融合蛋白。该试剂盒特别适用于使用TAP（串联亲和纯化）技术分离蛋白复合物。
适用质谱分析和蛋白质免疫印迹。
更多产品信息，请访问我们的FLAG®应用页面。
适用质谱分析和蛋白质免疫印迹。
更多产品信息，请访问我们的FLAG®应用页面。
Legal Information
FLAG is a registered trademark of Merck KGaA, Darmstadt, Germany
试剂盒组分也可单独购买
产品编号
说明
化学品安全说明书 & 价格
- Monoclonal Anti-HA−Agarose antibody produced in mouse, clone HA-7, purified immunoglobulin, PBS suspension
存储类别
10 - Combustible liquids
wgk
WGK 3
signalword
Danger
hcodes
Hazard Classifications
Aquatic Chronic 3 - ED ENV 1 - Eye Irrit. 2
商品
The FLAG® HA tandem epitope system consists of small epitopes tags that are not eukaryotic derived. These features minimize interference with protein functions and provide superior specificity.
相关内容
Protein and nucleic acid interaction reagents and resources for investing protein-RNA, protein-DNA, and protein-protein interactions and associated applications.
Protein expression technologies for various expression systems supporting research, therapeutics, and vaccine production.
Protein purification techniques, reagents, and protocols for purifying recombinant proteins using methods including, ion-exchange, size-exclusion, and protein affinity chromatography.
Junsong Zhang et al.
Journal of virology, 90(8), 3966-3980 (2016-02-05)
The viral ribonucleoprotein (vRNP) complex of influenza A viruses (IAVs) contains an RNA-dependent RNA polymerase complex (RdRp) and nucleoprotein (NP) and is the functional unit for viral RNA transcription and replication. The vRNP complex is an important determinant of virus
Wei Li et al.
Cell, 140(4), 477-490 (2010-02-25)
Current models imply that the FERM domain protein Merlin, encoded by the tumor suppressor NF2, inhibits mitogenic signaling at or near the plasma membrane. Here, we show that the closed, growth-inhibitory form of Merlin accumulates in the nucleus, binds to
Karthik Ramachandran et al.
iScience, 25(1), 103722-103722 (2022-01-11)
SARS-CoV-2 is a newly identified coronavirus that causes the respiratory disease called coronavirus disease 2019 (COVID-19). With an urgent need for therapeutics, we lack a full understanding of the molecular basis of SARS-CoV-2-induced cellular damage and disease progression. Here, we